Institutional Experience of Interstitial Brachytherapy for Head and Neck Cancer with a Comparison of High- and Low Dose Rate Practice |
Mohanti, Bidhu Kalyan
(Department of Radiation Oncology, All India Institute of Medical Sciences)
Sahai, Puja (Department of Radiation Oncology, All India Institute of Medical Sciences) Thakar, Alok (Department of Otolaryngology and Head-Neck Surgery, All India Institute of Medical Sciences) Sikka, Kapil (Department of Otolaryngology and Head-Neck Surgery, All India Institute of Medical Sciences) Bhasker, Suman (Department of Radiation Oncology, All India Institute of Medical Sciences) Sharma, Atul (Department of Medical Oncology, All India Institute of Medical Sciences) Sharma, Seema (Department of Radiation Oncology, All India Institute of Medical Sciences) Bahadur, Sudhir (Department of Otolaryngology and Head-Neck Surgery, All India Institute of Medical Sciences) |
1 | Okura M, Aikawa T, Sawai NY, Iida S, Kogo M (2009). Decision analysis and treatment threshold in a management for the N0 neck of the oral cavity carcinoma. Oral Oncol, 45, 908-11. DOI |
2 | Umeda M, Komatsubara H, Ojima Y, et al (2005). A comparison of brachytherapy and surgery for the treatment of stage I-II squamous cell carcinoma of the tongue. Int J Oral Maxillofac Surg, 34, 739-44. DOI |
3 | Urashima Y, Nakamura K, Shioyama Y, et al (2006). Long-term functional outcome of brachytherapy for carcinoma of the mobile tongue: focus on the atrophic change of irradiated tongue. Jpn J Clin Oncol, 36, 681-7. DOI |
4 | van Wilgen CP, Dijkstra PU, van der Laan BF, Plukker JT, Roodenburg JL (2004). Morbidity of the neck after head and neck cancer therapy. Head Neck, 26, 785-91. DOI |
5 | Wang X, Liu R, Ma B, et al (2010). High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer. Cochrane Database Syst Rev, 7, 7563. |
6 | Wensing BM, Merkx MA, De Wilde PC, Marres HA, Van den Hoogen FJ (2010). Assessment of preoperative ultrasonography of the neck and elective neck dissection in patients with oral squamous cell carcinoma. Oral Oncol, 46, 87-91. DOI ScienceOn |
7 | Guinot JL, Santos M, Tortajada MI, et al (2010). Efficacy of high-dose-rate interstitial brachytherapy in patients with oral tongue carcinoma. Brachytherapy, 9, 227-34. DOI |
8 | Ghadjar P, Bojaxhiu B, Simcock M, et al (2012). High doserate versus low dose-rate brachytherapy for lip cancer. Int J Radiat Oncol Biol Phys, 83, 1205-12. DOI |
9 | Glatzel M, Buntzel J, Schroder D, Kuttner K, Frohlich D (2002). High-dose-rate brachytherapy in the treatment of recurrent and residual head and neck cancer. Laryngoscope, 112, 1366-71. DOI |
10 | Greene FL, Page DL, Fleming ID, et al (2002). AJCC Cancer Staging Manual. 6th edn. Springer-Verlag, New York. |
11 | Inoue T, Inoue T, Yoshida K, et al (2001). Phase III trial of highvs. low-dose-rate interstitial radiotherapy for early mobile tongue cancer. Int J Radiat Oncol Biol Phys, 51, 171-5. |
12 | Kakimoto N, Inoue T, Inoue T, et al (2003). Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer. Radiother Oncol, 68, 123-8. DOI ScienceOn |
13 | Masuda M, Kuratomi Y, Shiratsuchi H, et al (2000). Decreased CD44H expression in early-stage tongue carcinoma associates with late nodal metastases following interstitial brachytherapy. Head Neck, 22, 662-5. DOI |
14 | Mazeron JJ, Noel G, Simon JM (2002). Head and neck brachytherapy. Semin Radiat Oncol, 12, 95-108. DOI |
15 | Mazeron JJ, Ardiet JM, Haie-Meder C, et al (2009). GECESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas. Radiother Oncol, 91, 150-6. DOI |
16 | Mohanti BK, Bansal M, Bahadur S, et al (2001). Interstitial brachytherapy with or without external beam irradiation in head and neck cancer: Institute Rotary Cancer Hospital experience. Clin Oncol, 13, 345-52. |
17 | Bartochowska A, Wierzbicka M, Skowronek J, Leszczynska M, Szyfter W (2012). High-dose-rate and pulsed-dose-rate brachytherapy in palliative treatment of head and neck cancers. Brachytherapy, 11, 137-43. DOI |
18 | Borgemeester MC, van den Brekel MW, van Tinteren H, et al (2008). Ultrasound-guided aspiration cytology for the assessment of the clinically N0 neck: factors influencing its accuracy. Head Neck, 30, 1505-13. DOI |
19 | Cox JD, Stetz J, Pajak TF (1995). Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys, 31, 1341-6. DOI ScienceOn |
20 | Concato J, Shah N, Horwitz RI (2000). Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med, 342, 1847-92. |
21 | Ganly I, Patel S, Shah J (2012). Early stage squamous cell cancer of the oral tongue-clinicopathologic features affecting outcome. Cancer, 118, 101-11. DOI ScienceOn |
22 | Nag S, Cano ER, Demanes DJ, Puthawala AA, Vikram B; American Brachytherapy Society (2001). The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma. Int J Radiat Oncol Biol Phys, 50, 1190-8. DOI |
23 | Soares HP, Kumar A, Daniels S, et al (2005). Evaluation of new treatments in radiation oncology: are they better than standard treatments? JAMA, 293, 970-8. DOI |
24 | Yamazaki H, Inoue T, Yoshida K, et al (2003). Brachytherapy for early oral tongue cancer: low dose rate to high dose rate. J Radiat Res, 44, 37-40. DOI |
25 | Yamazaki H, Inoue T, Yoshida K, et al (2004). Lymph node metastasis of early oral tongue cancer after interstitial radiotherapy. Int J Radiat Oncol Biol Phys, 58, 139-46. DOI |
26 | Nose T, Koizumi M, Nishiyama K (2004). High-dose-rate interstitial brachytherapy for oropharyngeal carcinoma: results of 83 lesions in 82 patients. Int J Radiat Oncol Biol Phy, 59, 983-91. DOI |